Pelthos Therapeutics Inc. (PTHS)
(Delayed Data from AMEX)
$19.93 USD
-0.09 (-0.45%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $19.15 -0.78 (-3.91%) 7:12 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Pelthos Therapeutics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PTHS 19.93 -0.09(-0.45%)
Will PTHS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PTHS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for PTHS
Pelthos Therapeutics (PTHS) Sees Price Target Boost Post-Merger | PTHS Stock News
Pelthos Therapeutics target adjusted at Alliance after merger, reverse split
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
Pelthos Therapeutics Launches First At-Home Prescription Gel For Highly Contagious Skin Disease